Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care Dividend Announcement
• Fresenius Medical Care announced a annually dividend of $0.69 per ordinary share which will be made payable on 2024-06-03. Ex dividend date: 2024-05-17
• Fresenius Medical Care annual dividend for 2024 was $0.69
• Fresenius Medical Care annual dividend for 2023 was $0.67
• Fresenius Medical Care's trailing twelve-month (TTM) dividend yield is 3.45%
• Fresenius Medical Care's payout ratio for the trailing twelve months (TTM) is 52.99%
• Fresenius Medical Care's dividend growth over the last five years (2018-2023) was 1.13% year
• Fresenius Medical Care's dividend growth over the last ten years (2013-2023) was 3.16% year
Fresenius Medical Care Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-17 | $0.69 | annually | 2024-06-03 |
2023-05-17 | $0.67 | annually | 2023-06-01 |
2022-05-13 | $0.74 | annually | 2022-05-27 |
2021-05-24 | $0.83 | annually | 2021-06-07 |
2020-08-28 | $0.84 | annually | 2020-09-11 |
2019-05-17 | $0.66 | annually | 2019-05-31 |
2018-05-21 | $0.63 | annually | 2018-06-04 |
2017-05-11 | $0.51 | annually | 2017-05-26 |
2016-05-10 | $0.44 | annually | 2016-05-23 |
2015-05-15 | $0.44 | annually | 2015-06-01 |
2014-05-13 | $0.73 | annually | 2014-05-27 |
2013-05-14 | $0.49 | annually | 2013-05-28 |
Fresenius Medical Care Dividend per year
Fresenius Medical Care Dividend growth
Fresenius Medical Care Dividend Yield
Fresenius Medical Care current trailing twelve-month (TTM) dividend yield is 3.45%. Interested in purchasing Fresenius Medical Care stock? Use our calculator to estimate your expected dividend yield:
Fresenius Medical Care Financial Ratios
Fresenius Medical Care Dividend FAQ
Other factors to consider when evaluating Fresenius Medical Care as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Fresenius Medical Care stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Fresenius Medical Care's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Fresenius Medical Care publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Fresenius Medical Care distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Fresenius Medical Care are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Fresenius Medical Care sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Fresenius Medical Care distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Fresenius Medical Care declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Fresenius Medical Care's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Fresenius Medical Care's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.